Aslan
ClosedSingapore, Singapore · Founded 2010 · $76.0M raised
- Headquarters
- Singapore
- Employees
- 11–50
- Founded
- 2010
- Business Model
- B2B
- Website
- aslanpharma.com
- Total Funding
- $76.0M
- Last Round
- $20.0M Venture RoundMar 2023
- Rounds
- 5
About
ASLAN Pharmaceuticals is a Singapore-based clinical-stage biopharmaceutical company developing immunotherapies and targeted agents for indications including atopic dermatitis and autoimmune conditions. Its lead candidate, eblasakimab, is an antibody targeting the IL-13 receptor. Founded in 2010 by Carl Firth, ASLAN listed on Nasdaq in 2018 and has raised capital across venture, pre-IPO and post-IPO rounds from investors such as Accuron Technologies (a Temasek subsidiary), BVF Partners and K2 HealthVentures.
Summary
Aslan is a Biotech company based in Singapore, Singapore, founded in 2010. It has raised $76.0M in total across 5 rounds, most recently a $20.0M Venture Round round in Mar 2023.
Funding History
Sign up to view the funding chart
Create a free account with 25 free credits every month, no card needed, to unlock funding history, valuations, and tech stacks.
Mar 2023
Sign up to see all 6 rounds
Seed through Venture Round — per-round amounts, valuations, and who invested in each round.
Similar Companies
China's leading blood products manufacturer
IVI-RMA provides fertility treatments and patient-centered reproductive care, combining research,...
inVentiv Health merged with INC Research to form Syneos Health, integrating clinical and commerci...
Altos Labs combines academic science and industry development to create medicines that restore ce...
Specialty pharmaceutical company
BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/aslan"><img src="https://indexed.vc/api/badge/company/aslan" alt="Aslan on Indexed.vc" width="260" height="76" /></a>